Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: R01BA52

Aerinaze(desloratadine;pseudophedrine sulfate)

Rhinitis, Allergic, Seasonal

Marketing Authorisation Holder: Organon N.V.

EMA Authorisation: 30/07/2007

INN: desloratadine;pseudoephedrine

Indication

Symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Aerinaze — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.